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With the increasing use of genetically modified organisms there is a growing need for 
biocontainment in order to secure biosystems from outside malice as well as to prevent 
propagation in an open system in the event of advertent or inadvertent release to the 
environment. Although recombinant DNA technology was established more than four 
decades ago (1) the fact that genetically modified organisms have not caused any 
substantial deleterious incident is due in part to precautionary measures taken by 
professional genetic engineers and the high cost of genetic engineering, largely restricting 
its use to academic and industrial labs. However, in the current era of DIY synthetic 
biology, with rapid technological advances in DNA synthesis and assembly (2), genome 
editing (3, 4) and computational tools for design (5-7), and with the decreasing cost of 
DNA synthesis, the need for genomic safeguards is clear.  
 
Early biocontainment efforts focused on the use of metabolic auxotrophy dependence (8, 
9), toxin/antitoxin dependent suicide (10-13) or both (14, 15). Although top performers 
using these strategies do comply with the NIH standard for safeguards (10-8 escape rate), 
they are at risk for cross-feeding and the need for micromolar concentrations of nutrients, 
making them costly for industrial scale-up. Recent work has focused on recoded 
Escherichia coli with synthetic auxotrophy to a non-natural amino acid (16, 17), showing 
robust growth maintained for generations as well as an escape rate of less than 10-11. In 
addition, previous work from our lab has shown engineering of a yeast strain carrying 
multiplex biocontainment combining transcriptional and recombinational based 
safeguards, reaching an escape rate of less than 10-10 (18). This was achieved in part with 
transcription control of a single essential gene with an escape rate of 10-6, however this 
could potentially be lowered by fine-tuning of the safeguard construct, reducing the 
multiplex escape rate to a much lower value. Here we focus on develop such enhanced 
transcriptional safeguards that are about an order of magnitude more “secure” 
individually. Also, analysis of the escapers provides insights into their molecular basis 
and potentially can help engineer reduced escape rates in the future. Finally, there may be 
many other generic uses for tightly controlled essential genes in fundamental genetic 
studies. 
 
The yeast Saccharomyces cerevisiae is a critically important host for fermentation and 
production of many biomedically and industrially critical products  (19). In our attempts 
to find best-acting transcriptional safeguard(s) for yeast cells we sought a construct 
achieving the following criteria: fitness approaching the wild type in permissive 
conditions, lowest possible escape rate under restrictive conditions and essential growth 
supplement in a nanomolar scale. We screened a library of essential genes to find the best 
acting genes. Using combinatorial assembly we screened for the best acting promoters 
and terminators, and finally, we used further genetic engineering to fine-tune safeguard 
constructs.   
 
In addition, we examined components that might be employed in a setting where the aim 
is to prevent the theft of intellectual property in the form of a living strain. To this end, 
we performed an analysis of harmless but ineffective regulatory genes and “decoy 
molecules” which could be employed to mask potential proprietary components used in 
safeguarded strains and the medium on which they depend in an industrial setting, to 
discourage their reverse engineering.  
 
Results  
 
Broad screen for candidate essential genes to be incorporated into safeguards  
Our previously described transcriptionally regulated safeguards (SGs) consist of a 
promoter regulated by an externally supplied ligand, driving the expression of one or 
more essential genes (18).  For these to meet the requirements of 1) robust growth in the 
presence of the ligand and 2) complete failure to grow or loss of viability in the absence 
of ligand, we sought yeast genes best adapted to the purpose.  Such genes are expected to 
tolerate a certain variation in their expression without a fitness penalty, but stop growing 
entirely, or lose viability when expression falls below a certain threshold- i.e. they should 
not display “leaky growth” when minimally expressed. To identify potential safeguard 
essential genes we began by identifying the 250 strains from the Yeast Tet-Promoters 
Hughes Collection (yTHC) annotated as having a “Severe” or “Very Severe” phenotype 
on Doxycycline in a “Tet-OFF” strain background (20). These 250 strains, as well as a 
WT control (Strain R1158) were grown in YPD medium, diluted serially and plated on 
YPD, YPD+G418 (selecting for the integrated Tet promoter-essential gene expression 
cassette) and YPD+10 µg/mL Doxycycline. All strains grew as expected both on YPD 
and on YPD+G418, but, as expected, showed various colony sizes (fitness) in the 
presence of doxycycline. In addition, the different strains also showed various fitness 
levels in the absence of doxycycline. From the 250 strains initially chosen for this 
analysis we chose to continue with a subset of 47 strains, all of which showed high 
fitness (similar to WT) on YPD, and low fitness in the presence of Doxycycline 
(Supplementary Figure S1).  
 
Building shuffle strains for combinatorial screening of safeguard strains 
Because our safeguard strategy relies on using essential genes, we must introduce the 
safeguard transcription units (SGTUs) into a yeast strain that already expresses the gene 
of interest.  Having the “unguarded” copy of the gene on a URA3 “shuffle plasmid” 
allows quick and efficient spontaneous plasmid loss in the presence of ligand, leaving 
only the safeguarded copy. Thus we constructed 49 haploid “shuffle strains”, carrying a 
deletion of each essential gene as well as a shuffle plasmid with a wild type copy of the 
essential gene and a URA3 marker, enabling its loss using 5-Foa counter selection (21).  
 
To create shuffle plasmids for each candidate gene we amplified the corresponding CDS 
(coding sequence) from the genome with 500bp upstream and 200bp downstream 
sequences, to include the native promoter and terminator sequences.  The primers used 
for the genome amplification include 50bp overhangs, which served as recombination 
sites with pRS416 (Figure 1). Each PCR product was co-transformed with linearized 
pRS416 [a centromeric URA3 plasmid (22)] into a diploid strain heterozygous for the 
corresponding essential gene. Homologous recombination between the PCR product and 
the vector facilitated construction of a shuffle plasmid containing URA3 and the essential 
gene in vivo (Figure 1). These Ura+ diploids were sporulated and dissected to isolate 
“shuffle strains”: haploids containing the shuffle plasmid and lacking the essential gene 
of interest. Of the 49 candidates we successfully constructed shuffle strains for 45 
potential SGTUs.  
 
Combinatorial yGG assembly of safeguard constructs  
Having the ability to combinatorially assemble SGTUs provides many more variants for 
testing than could be made individually. Thus, we assembled our SG constructs as a 
combinatorial yeast Golden Gate (yGG) assembly (23) and screened for the best 
candidates in yeast.  We amplified all the parts (promoters, essential gene CDSs, and 
terminators) from the yeast genome with the appropriate yGG overhangs, as described 
(23). For each essential gene we performed a “one pot” yGG assembly, adding 6 distinct 
galactose-regulated promoters [GAL1, GAL7, GAL10, SPAL2, SPAL5 and SPAL6 (24)], 
GAL1 terminator and acceptor vector (pAV10.HO5.loxP). The SPAL promoters were of 
special interest because earlier work showed that these promoters greatly reduced the 
leakiness of the associated CDSs (24); the number following the name SPAL indicates 
the number of GAL4 recognition sequences in the promoter. Following yGG assembly, 
the reaction mix was transformed into bacteria and grown in liquid medium, producing a 
bulk plasmid prep which was digested to evaluate assembly efficiency. Assembly 
efficiency is evaluated by digesting the bulk plasmid prep with NotI (flanking the 
assembled SGTU and the homologous arms for integration) which revealed a band 
corresponding to the size of the assembled TU (data not shown).   
 
Screening for candidate safeguard strains  
Following combinatorial yGG assembly and verification, each assembly was transformed 
into its corresponding yeast shuffle strain.  Transformations were plated on SGal–Leu to 
allow expression of the promoters and enable loss of the shuffle plasmid. Transformed 
colonies were then replica plated to SC+5-Foa 2% galactose plates. In most cases the 
majority of the colonies were 5-Foa resistant. 10 FoaR isolates were chosen from each 
gene and were plated on YPD and YPGAL to assess ability to serve as a safeguard strain 
(Supplementary Figure S2). Note that there are significant differences between genes as 
well as between variant TUs containing the same CDS, presumably reflecting distinct 
promoter characteristics. The 12 candidate genes were chosen that perform best (they 
grew well on YPGAL and showed low background growth on YPD; Figure 2A). 8 
isolates from each of 12 essential genes were chosen, and subsequently transformed with 
pRS416-GEV, which expresses the GAL4-estrogen binding domain-VP16 transcriptional 
activator, and is activated by low concentrations of estradiol (25). Each strain was 
transformed with empty vector as a negative control. The optimal SG candidates should 
grow well with Estradiol (SC–Ura + estradiol) and should show a very low or no growth 
on SC–Ura without estradiol. Figure 2B shows the best 5 strains out of the 12 essential 
genes plated on SC–Ura+ 30nM Estradiol vs. SC–Ura.  As shown in Supplementary 
Figure S3, we had a large number of “good” candidate strains to choose from. We 
continued after selecting 3 “good” strains from each of the 5 SGs (Except for RPB11, 
which had only one good strain).  
 
All 13 strains were examined for doubling time in SC–Ura + 30nM estradiol. They were 
all compared to their corresponding shuffle strain (Figure 2C). Similarly to the previously 
described histone H3/H4 SG strain (18), all SG strains show a slight increase in doubling 
time compared to the shuffle strain, which we attribute to the influence of induction of 
endogenous GAL genes by estradiol (26). Of the 13 we chose one SG strain for each 
essential gene to follow up with an escape (reversion) rate experiment, as a final test for 
optimality, and identification of the promoters.  
 
In addition, comparison of the three best SG strains identified here with the previously 
published ones (18) shows significantly lower background growth on YPD medium 
compared to YPGAL (Figure 2D), indicating that this screen enabled selection of better 
performing SG strains.     
 
Measuring fitness of safeguard strains  
Due to the fact that these strains were created in a combinatorial assembly strategy and 
chosen from a pool of safeguards, we decided to evaluate performance using individually 
constructed plasmids, and to evaluate robustness in distinct genotypic backgrounds, we 
tested in both MATa and MAT host strains. This was done using yeast Golden-Gate 
(yGG) assembly transformed into yeast as described above.  Candidates were plated on 
medium with or without 30nM Estradiol for verification. The results were similar to the 
counterparts made using combinatorial assembly (data not shown) in both mating types. 
To evaluate fitness of the strains we measured their growth rate and calculated their 
doubling time compared to WT strain carrying the GEV plasmid (Figure 3A). Growth 
rate in all three safeguard strains shows little to no difference from the control strain.  
In order to examine the difference between safeguard strains and control we preformed 
transcriptome and metabolomics profiling (Figure 3, Supplementary Table S1). 
Transcriptome analysis showed that in most of the SG strains there are only 0-7 genes 
which showed a significant change in transcript level (Table S1). Only one SG strain, 
RPB11 MATa, showed a larger number of transcripts that changed significantly compared 
to the control strain.  
 
For metabolomics profiling we compared each strain to a WT strain carrying the GEV 
plasmid. Figure 3C shows a heat-map of the different metabolites and their fold 
difference compared to their control (Supplementary Table S2). In all strains (both MATa 
and MAT) there was almost no detectable difference compared to the control stain. In 
agreement with the transcriptome and growth rate analyses these safeguard strains show 
little to no differences from the control strain.  
 
Importantly, fitness was measured compared to a control carrying the GEV expression 
plasmid, this was done based on a previous observation that expression of the GEV 
construct causes a global activation of Gal-UAS regulated genes and thus reduces growth 
rate of the strain (26). A solution to this limitation is discussed below.  
 
In addition, we measured the escape rate of our SG strain, all 5 SG strains had less than 
10-7 escapers per cell division (Table 1).  
 
 
 
 
Analysis of escapers (revertants) 
Escape rate experiments were performed on our safeguard strains; 16 independent 
escapers were isolated from each strain (8 MATa and 8 MAT For complementation 
group analysis, strains were replica-plated in a crisscross pattern to allow for mating at 
the junctions. Mating was performed on SC–Ura permissive medium containing estradiol, 
and then replica plated to SC–Met–Lys–Ura + estradiol selecting for diploids and finally 
replica plated to SC–Met–Lys–Ura without estradiol for analysis of complementation 
groups. Escapers that originated via a recessive mutation in the same gene fail to 
complement and thus grow on medium lacking estradiol. In contrast, escapers originating 
from recessive mutants in different genes will complement and fail to grow on medium 
lacking estradiol. In addition, backcrosses to the original SG strain indicate whether the 
mutation is recessive or dominant. Table 2 summarizes the complementation analyses. 
We isolated 8 complementation groups for FAS2 SG escapers and 7 complementation 
groups for SEC4 SG escapers. For RPB11, all escapers belong to the same 
complementation group, excepting R3 which showed a dominant phenotype. One 
candidate from each complementation group was selected for further analysis.  
 
In order to analyze the location (GEV plasmid or genome) of the mutation in each 
escaper, we isolated the plasmid from each escaper strain analyzed and sequenced it. 
Digestion of plasmid DNA revealed that all but one (RPB11 MATa R1) showed a similar 
plasmid digest pattern as the original plasmid (Supplementary Figure S4). Sequencing of 
the plasmid isolated from RPB11 MATa R1 showed a 684bp deletion in the Estrogen 
Binding domain (EBD). This explains both the growth in the absence of estradiol due to 
constitutive localization in the nucleus and well as the escaper’s dominant phenotype.  
 
To locate the mutations in the remaining escapers we performed the following:  1) Cured 
each escaper of its GEV plasmid; 2) Transformed the isolated plasmids into the original 
corresponding safeguard strain and 3) Transformed a WT plasmid (pRS416-GEV) into 
the cured escaper (point 1). 
 
All of these were plated as serial dilutions on SC–Ura supplemented with 2% Galactose, 
SC–Ura + 30nM Estradiol and SC–Ura (Supplementary Figure S5). In all but one strain 
(RPB11 MATa R1), these experiments indicated that the mutation was in the genome, as 
transforming the isolated plasmid from the escapers did not confer the capability to grow 
without estradiol, however, the cured strain transformed with the original WT plasmid 
(pGEVnew) reconstituted the escaper phenotype.  
 
We also analyzed the escapers cured of the plasmid on YPGAL medium (Supplementary 
Figure S6). Interestingly, all escapers showed a significantly slower growth rate in 
YPGAL compared to the original SG, conferring a fitness disadvantage compared to the 
original SG strains. This was also observed (to a lesser extant) when escapers were plated 
on SC–Ura + 30nM Estradiol (Supplementary Figure S5), which conferred a fitness 
disadvantage relative to the original SG strains . 
 
In order to locate the genomic mutations in these escapers we performed whole genome 
sequencing (one from each complementation group). In all but one, RPB11 R3, genome 
sequencing revealed mutations in one of the five components of the Rpd3L complex 
(Table 3). This complex represses transcription of URS1-containing genes by 
deacetylation of histone H3 and H4 in the promoter (27).  Due to the fact that all of our 
high-performing SG constructs are driven by a SPAL promoter (24) which contains the 
URS1 sequence to minimize background expression (28), mutations in genes encoding 
the components of the Rpd3L complex are predicted to alleviate the repression and cause 
expression of the SG gene even in the absence of estradiol. In RPB11 R3, there was a 
single bp mutation of the URS1 sequence (AGCCGCCGA to AGCTGCCGA) which 
presumably prevents binding of Rpd3L to the promoter and explains the dominant 
phenotype of this escaper. The identification of the mutations also explains the fitness 
defect in the permissive media; these mutants are known to have intrinsic slow growth 
defects. Since 100% of the mutations we isolated in SEC4 and FAS2 SG strains were 
recessive, we expect that the escape rate could be lowered substantially by use of diploid 
host strains.  Thus, by crossing the SG strains from the two mating types we engineered 
diploid SG strains for both FAS2 and SEC4. In both cases the diploids shows reduced 
escaper rate in media without Estradiol (Figure 4A).  
 
To verify the effect that mutations in Rpd3L component genes have on SG strains, we 
deleted UME6 in the FAS2 MATa SG strain. As a control, we deleted a member of the 
Rpd3S complex, EAF3. As seen in Figure 4B, deletion of UME6 but not EAF3 
completely recapitulated the escaper phenotype, including a slight growth defect in 
medium with estradiol. 
 
Further improvements to safeguard strains.  
As mentioned above, expression of the GEV construct causes a modest fitness defect 
thought to be due to off-target effects due to expression of UAS containing promoters in 
the genome. This was previously reported by McIsaac and colleagues (26) and a possible 
alternative to the GEV system was suggested by the same group, namely the ZEV system 
(26). In the ZEV system the transcription factor (VP16) is fused to an Estrogen-Binding-
Domain (EBD) and a Zinc-finger binding domain recognizing a 9 bp sequence that was 
cloned into a minimal GAL1 promoter. The ZEV system was shown to have no effect on 
growth rate in yeast cells presumably due to the absence of native binding sites for this 
zinc finger protein. Based on the much lower background of the SPAL promoter 
compared to native GAL promoters, we decided to clone the Z4 array containing 6 
binding sites into the SPAL promoter , replacing the GAL4 recognition sites (Figure 5A 
and Supplementary Data). This promoter is expected to be as tight as the SPAL promoter 
due to its URS1 sequence (transcribing only in the presence of estradiol and the ZEV 
protein) and as specific as the ZEV system (no off-target effect). We called the new 
chimeric promoter the “SPAZ” promoter.  
 
Following the synthesis of the SPAZ promoter we used it to drive expression of the 3 
best-performing SG genes (FAS2, RPB11 and SEC4). Serial dilutions on media with or 
without 1 µM estradiol showed that in all three cases growth with estradiol is 
indistinguishable from that of the shuffle strain. There was a significant reduction in 
viability (death) on plates without estradiol (Figure 5B). In addition, growth rate analysis 
showed that in YPD medium supplemented with 30 nM estradiol all three SPAZ SG 
strains show growth similar to the BY4741 wild-type strain (Figure 5C). Metabolomics 
analyses showed no significant change in any of the metabolites examined compared to a 
WT strain, further underscoring the normal physiology of strains safeguarded by this 
mechanism (Figure 5D and Supplementary Table S3).  
 
Reducing background of a yeast TET promoter  
In addition to the GAL promoters and their derivatives, other well-studied switches are 
based on the TET system, previously used in yeast (29) and other organisms. We wished 
to construct a TET-based SG strain. Unfortunately, the current TET system available to 
us (29, 30) was too leaky and showed no significant reduction in growth without 
Doxycycline for all of our 44 essential genes SGs. Therefore, based on success with the 
SPAL and SPAZ promoters, we assembled a “SPET” promoter. This promoter is based 
on the TET promoter used in our lab (Figure 6A) with a URS1 sequence inserted 
downstream of the TATA box and upstream of the estimated transcription start site 
(Figure 6A).  
 
First, we cloned either a single URS1 (SPET) or 3 repeats of the URS1 sequence 
(3xSPET) into the TET promoter. These promoters were then cloned into an acceptor 
vector for safeguard gene integration (pSIB499). For examining the function of the SPET 
promoter we cloned one of our candidate essential genes, SEC4, under the control of the 
TET, SPET or 3xSPET promoters and analyzed the expression with or without 
Doxycycline (Figure 6B), compared to a strain carrying a WT copy of SEC4. The 
3xSPET promoter showed almost 4-fold reduction in growth without doxycycline (YPD) 
compared to both the SPET and the TET promoters. However, although very slight, all 
three SPET promoters show a growth defect compared to expression of the SG genes 
driven by their native promoters. Thus, with relatively simple tweaks, the TET promoter 
can also serve as a SG switch. 
 
Screening a library of decoy molecules   
One key feature of a specific application for safeguard strains, namely to guard 
proprietary elements of the strain e.g. in industrial applications, is the ability to prevent 
outside sources from propagating the strains without previous knowledge of the very 
specific medium requirements of a given SG strain. In addition to enabling growth in 
very low concentrations of the required compound the identity of that compound could be 
masked using an array of distinct but inert “decoy” molecules. A major requirement for 
such decoy molecules is that they should not by themselves have any deleterious effect 
on the growth or physiology of the yeast strain. Ideally this should also be true of any 
ligand actually used to activate the SG.  With this in mind, we analyzed the transcriptome 
of yeast cells (BY4741) in the presence of 22 compounds (Table S4), at two 
concentrations each to evaluate their physiologic impact. They were separated into three 
groups based on the solvent used (Water, DMSO or Ethanol) and the transcriptome were 
compared to a solvent control. Analysis of the transcriptome of cells exposed to the 
compounds revealed that in many cases there is a strong effect on transcription (Figure 7 
and supplementary Table S5). However, several compounds produce only minor changes 
(1-3 genes) or even no change at all (Figure 7 and supplementary Table S5). The latter 
group contains the best candidates as ligands for future gene regulatory systems for 
safeguards. 
 
 
Discussion 
The growing need for biocontainment in industrial production settings, and in industry 
and academic labs, and more important, as a containment mechanism for potential field 
release of recombinant organisms, has led to an investment in designing safeguard 
strains. Efforts have been made both in bacteria (10-12, 15-17) and yeast (18). 
Interestingly, it has been shown that in order to achieve an extremely stable safeguard 
strain with as few escapers as possible there is a need to multiplex distinct strategies of 
biocontainment. To do so it is imperative to have a large array of possible essential genes 
that are good candidates to act in a safeguard system.  
 
Here screening a library of 250 essential genes and narrowed this down to three best-
acting genes (FAS2, RPB11 and SEC4) under estradiol induction. In our screen we also 
selected the best acting promoter for each gene out of 6 possible candidates. We 
eventually selected for constructs that showed the lowest possible escape rate with the 
least measurable effect on growth compare to a control strain.  This screen allowed us to 
achieve an escape rate of less than 10-7 with only a single essential gene; compared to 10-
6 observed previously (18) for a single gene and closer to 10-9 that was observed for two 
histone genes. In a diploid context this escape frequency dropped by at least another 
order of magnitude. It is quite possible that these three genes are good candidates for the 
GAL/estradiol system but might very well not work as well in when controlled by other 
ligand activated promoters. However, similar workflows can easily be utilized with any 
other transcription system and might identify additional suitable candidates.  
 
We have also shown that using promoter engineering we can decrease a deleterious 
genome-wide effect on endogenous GAL promoters using synthetically designed zinc-
finger (26) and TET promoters, by improving promoter leakiness using a natural URS 
sequence (Figure 5). Although further optimization is required to adjust the appropriate 
dynamic range of the Tet system, its addition to the SG toolbox will help multiplex SG 
constructs and may reduce escape rates even further.   
 
Analysis of escapers indicated that the use of the URS sequences also represents a weak 
spot of these promoters, as almost all revertants mapped to genes encoding Rpd3L 
complex subunits that repress transcription of genes carrying a URS1 sequence (27). 
Knowing this, with the fact that in all cases the mutation was recessive, future safeguards 
could either be constructed in a diploid background or supplemented with extra copies of 
the Rpd3L complex genes to reduce escape rates significantly.  
 
Nevertheless, the best strategy to decrease the escape rate in safeguard strains will be to 
use multiplexed safeguards that will serve as backups to one another in case one fails due 
to naturally occurring mutations, which are part of any biosystem (18).  
 
Tightly controlled genetic switches regulating essential genes are also useful in many 
other genetic contexts such as the evaluation of essential gene function (i.e. gene shutoff 
studies) and perhaps in the study of interactions of essential genes in genome wide 
contexts (31). 
 
 
 
Material and Methods 
 
Strains, plasmids, oligonucleotides and media 
Yeast strains and the plasmids contained are listed in Supplementary Table S6. All SG 
strains are derived from BY4741 (MATa leu2∆0 met15∆0 ura3∆0 his3∆1) and BY4742 
(MAT leu2∆0 lys2∆0 ura3∆0 his3∆1) (22). Oligonucleotides used to amplify essential 
genes for shuffle plasmid construction are listed in Supplementary Table S7, other 
Oligonucleotides and primers used in this work are available upon request. Media used 
were as follows. Yeast strains were cultured in YPD medium, YP-galactose medium, or 
SD-based media supplemented with appropriate amino acids; fully supplemented 
medium containing all amino acids plus uracil and adenine is referred to as SC (32, 33). 
-Estradiol was purchased from Sigma-Aldrich (St. Louis, MO), and 5-fluoroorotic acid 
(5-FOA) was from US Biological (Massachusetts, MA). Doxycycline (Dox) was obtained 
from Clontech laboratories (Mountain View, CA). Escherichia coli was grown in Luria 
Broth (LB) media. To select strains with drug-resistant genes, carbenicillin (Sigma-
Aldrich) or kanamycin (Sigma-Aldrich) were used at final concentrations of 75 µg/ml 
and 50 µg/ml respectively. Agar was added to 2% for preparing solid media. Final 
concentrations of compounds and their solvents are listed in Table S4, 1000X stock 
solution was prepared for all compounds. Plasmids used are described in Table S8. SPAZ 
promoter sequence and SPET promoters sequence are listed in Supplementary data.  
 
Plasmid recovery from yeast 
Plasmid recovery from yeast was carried out using a Zymoprep yeast plasmid miniprep 
kit (Zymo Research, Irvine, CA) following the manufacturer’s instructions.  
 
Safeguard promoter identification 
For each strain, genomic DNA was extracted and the promoter region was amplified 
using the vector forward primer and a reverse primer 100bp downstream of the ATG. 
Each PCR fragment was sent for sequencing using the same primers. The results of the 
sequencing are summarized in Table 1.  
 
Escape rate measurement 
Escape rates were calculated using the method of the median (34). For measurement rates 
in the 10−5 to 10−9 range, 5–12 independent cultures (each grown from a single parent 
colony) were inoculated into 20 mL of media supplemented with 30nM estradiol in liquid 
cultures. In total, 108 and 107 cells were plated on restrictive medium. Viable titer was 
determined by plating 100 µL of a five to six serial 10-fold dilution on permissive 
medium. The reversion frequency was obtained by dividing colony-forming units on 
restrictive plates by colony-forming units on permissive plates. The median reversion 
frequency was then used to calculate the rate using the method of the median. 
 
For each SG strain to be measured, 8 “escaper” escaper colonies were picked from 
independently grown cultures and grown up in 10 mL of permissive liquid culture (with 
plasmid selection if applicable), for 48 h at 30°C. Tenfold serial dilutions were plated on 
restrictive and permissive agar plates, and incubated at 30°C for 2–3 d until single 
colonies appeared. One colony was chosen per culture to assure independence. 
 
Creating parts for combinatorial yeast Golden-Gate (yGG).  
In addition to the 47 strains chosen from the TET-off library we decided to add three 
additional genes (HSP10, RPC11 and SUI1) previously shown to be potential safeguard 
genes (18). All 50 genes were to be potentially cloned downstream of 7 different 
promoters: GAL1, GAL10, GAL7, SPAL2, SPAL10, SPAL7 (24). They were assembled 
with the GAL1 terminator and into an acceptor vectors with integration cassettes (23).  
All combinations were examined for their ability to serve as potential safeguards. All 50 
genes, 6 promoters and terminator were amplified with the appropriate overhangs for 
yGG from the yeast genome (23), cloned into a pCR-Blunt II-TOPO vector (Invitrogen) 
and sequence verified. Most genes were amplified as one part genes, however, some were 
either too large to amplify as one part or had an internal BsaI site, which is incompatible 
with yGG assembly (23), and thus were amplified as multiple gene parts compatible with 
yGG assembly. All but one gene, PSA1, failed at this step, so we moved forward with the 
successful 49 genes. In total we synthesized 67 gene parts, 6 promoter parts and one 
terminator part for the yGG assembly.  As an acceptor vector we chose to use 
pAV10.HO5.loxP, an integrating vector, with the LEU2 marker for integration into the 
HO locus (23).  
 
DNA-Seq and RNA-Seq  
Pair-end whole genome sequencing of escapers was performed using an 
IlluminaHiSeq2500 using TruSeq preparations kits. In total, 20 samples were sequenced 
with 19.5M – 33.5M paired reads generated per sample. The length of each read was 101 
base pairs. Quality control was performed using software FastQC version 0.11.2 (35). All 
the reads in FASTQ format were aligned to the S. cerevisiae reference genome 
constructed starting with the sequence for control strains (strain BY4741 BY4742 
genome sequences) using BWA version 0.7.8 with -P -M –R parameter settings (36). 
Approximately 86%-93% reads were aligned to the corresponding reference genome. 
Software SAMtools version 0.1.19 was used to call variants with mpileup -A -uf and 
bcftools view -bvcg parameter settings (37). The results were subjected to a set of post-
processing filters requiring (i) a minimum of 10x coverage per variant site; (ii) wild-type 
reads in < 10% of the total reads per site; (iii) Reads supporting the variant of the control 
sample in < 5%. RNA-Seq datasets were generated and analyzed as described in (18).  
 
Metabolite Extraction 
 Intracellular metabolites were extracted from yeast, using a method adapted from (38).  
Briefly, overnight cultures grown in the appropriate dropout SC medium with 30nM 
estradiol, and were then diluted to OD 0.1 and grown to OD 1.0 in the same medium.  
12.5 mL of culture was then rapidly quenched by addition into 37.5 ml of 60% 
methanol/10 mM Tricine, pH 7.4, that was maintained at −40°C to stop metabolism. 
After 5 min at −40°C, cells were spun at 2,500 × g for 2 min at 0°C, washed with 1 ml of 
the same buffer, and then resuspended in 1 ml of 75% ethanol/0.5 mM Tricine, pH 7.4. 
Intracellular metabolites were extracted by incubating at 80°C for 3 min, followed by 
incubation at 4°C for 5 min. Samples were spun at 16,100 × g for 1 min to pellet cell 
debris, and 0.9 ml of the supernatant was transferred to a new tube. After a second spin at 
16,100 × g for 1 min, 0.8 ml of the supernatant was transferred to a new tube, dried down 
using a speed-vac, and stored at −80°C until analysis.  
 
LC-MS/MS analysis 
Dried metabolites were analyzed as previously described by (39). The dried metabolites 
are resuspended in one of 3 buffers which allow a specific subset of metabolites to be 
retained by the LC column, which are then eluted off by a methanol gradient.  This 
explains in part why the number of times a metabolite is listed is variable.  Some 
metabolites can be detected by more than one of the three methods.  Furthermore, for 
each method, there are usually 2 listings for each metabolite that represent the two most 
abundant daughter fragments.  Occasionally, only one daughter fragment can be detected 
reliably, which is why a few metabolites are only listed once. 
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Table 1: SG strains promoters and escape rates.   
Essential Gene Promoter Escape rate* 
FAS2 SPAL5 6.6E-08 
HTS1 SPAL6 7.0E-08 
RPB11 SPAL5 1.9E-08 
SEC17 SPAL2 8.8E-08 
SEC4 SPAL2 6.5E-08 
* Escape rates were calculated according to method of the median (34) 
 
 
Table 2: Escaper complementation group analysis 
* R=recessive, D=Dominant; 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENE  Complementation Groups R/D* 
FAS2 Group 1: MATa (R1, R4, R5, R8) and MAT  (R9, R10, R13, R14, R15) 
Group 2: MATa R2 
Group 3: MAT a R3 
Group 4: MATa R6 
Group 5: MATa R7 
Group 6: MATR11 
Group 7: MATR12 
Group 8: MAT R16 
R 
R 
R 
R 
R 
R 
R 
R 
RPB11 R3  
All others same complementation group   
D 
R 
SEC4 Group 1: MATa (R2, R4, R5, R6, R7) and MAT  (R11, R12, R13, R15, R16) 
Group 2: MATa R1 
Group 3: MATa R3 
Group 4: MATa R8 
Group 5: MATR9 
Group 6: MATR10 
Group 7: MATR15 
R 
R 
R 
R 
R 
R 
R 
R 
 
Table 3: Genomic mutations found in escapers by DNAseq.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* indicates premature stop codon; † indicates frameshift; & indicates assumed secondary 
mutation.  Underlined genes encode subunits of the RPD3L deacetylase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SG Escaper Gene Mutation 
FAS2 R1 UME6 E75* 
FAS2 R2 RPD3 M1V 
FAS2  R3  RPD3 G312D 
FAS2 R6 DEP1 Y236* 
FAS2 R7 YTA12 T971A& 
SDS3 E71* 
FAS2 R11 RHO1 D129N& 
SIN3 3061insT† 
FAS2 R12 SIN3 Y630* 
FAS2 R16 DEP1 Y242* 
RPB11 R9 UME6 C165* 
SEC4 R1 RPD3 G309C 
SEC4 R2 UBP13 L67M& 
UME6 Q113* 
SEC4 R3 SDS3 Q65* 
SEC4 R9 SRL2 K74L& 
DEP1 E222* 
SEC4 R10  DEP1 512insC†  
SEC4 R14 UME6 W368* 
Figure and Figure legends  
 
 
 
Figure 1: Outline of steps to create shuffle strains.  Genes were amplified from the yeast 
genome with 500 bp upstream and 200 bp downstream as well as 50 bp in each end for 
recombination with the pRS416 vector. SmaI digested pRS416 and each amplified essential  gene 
were transformed into the appropriate heterozygous diploid strain. Transformations (30µL) were 
dripped onto Omnitrays and single colonies were picked. Shuffle plasmid cloning was verified 
using plasmid primers and a gene internal primer. Following plasmid verification all strains were 
sporulated and G418 resistant Ura+ colonies were saved (both MATa and MATalpha strains were 
saved). YFEG, Your favorite essential gene. 
 
 
 
 
 
 
 
  
Figure 2: Screening for best safeguard strain after integration of the SG construct. 
Following transformation into the shuffle strains, and plating on 5-Foa, 10 candidates from each 
essential gene were examined by plating on YPGAL vs. YPD. (A) 12 best performing strains, 
were chosen for GEV plasmid transformation. 8 isolates from each SG strain were transformed 
with GEV containing plasmid and analyzed using a dot assay on Dextrose without Estradiol. (B) 
13 good candidates that grew well on SC–Ura without estradiol and did not grow on SC–Ura 
without estradiol were chosen for further analysis. (C) Liquid cultures were diluted and subjected 
to OD measurements every 10 min for 24 h. A growth curve was created and doubling time was 
calculated for each strain. The experiment included 3 independent cultures for each strain in order 
to calculate SD. (D) A comparison of our three best SG strains with the previously published 
ones (18) shows a significantly lower growth on YPD medium compared to YPGal, indicating 
that this screen identified better performing SG strains.     
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: MATa and MAT safeguard strains compared to WT strain with GEV plasmid.  
(A) Graphic representation of relative doubling time of SG strains compare to WT with GEV 
plasmid. Liquid cultures were diluted and subjected to OD measurements every 10 min for a 24 h 
period. Doubling time was calculated as in Fig. 2. (B) Transcriptome profiling of the various 
safeguard strains. The graph is organized by gene/promoter pairs. Red dots in the volcano plots 
represent statistically significantly dysregulated genes (see Table S1 for lists of genes affected). 
Blue labeled dot represents SG gene in each sample. The transcriptome profiling shows limited 
transcriptome changes to the safeguard strains compared with the wild type. (C) Metabolomics 
analysis presented as a heat-map of the fold change for each metabolite analyzed. Formic (formic 
acid 0.1%) , TBA (10mM pH 5.0) and NH4 (5mM ammonium acetate) represents the solvents 
used to extract the yeast.   MATa Safeguard strains: NAy407 (FAS2), NAy409 (RPB11) and 
NAy411 (SEC4), MATa control – NAy461. MAT Safeguard strains: NAy408 (FAS2), NAy410 
(RPB11) and NAy412 (SEC4), MAT control – NAy462.  
 
 
 
 Figure 4: Analysis of safeguard escapers. (A) We hypothesized that because all of FAS2 and 
SEC4 escapers were due to recessive mutations, diploid safeguard strains will have lower escape 
rates. Serial dilutions of FAS2 and SEC4 diploid safeguard strain were compared to the original 
haploid safeguard strains and wt strains on the appropriate medium with and without estradiol. 
This shows that indeed the diploids show decrease escape rate compared to the haploid strains. 
(B) Genome sequencing revealed that all escapers carry a mutation in genes encoding subunits of 
the Rpd3L complex. In order to reconstitute the escaper phenotype in our SG strains we deleted 
ume6 in the FAS2 MATa SG strain. Serial dilution of FAS2 SG deleted for ume6, eaf3 and 
carrying a pRS416-GEV plasmid were plated in appropriate medium with and without estradiol. 
Cell deleted for ume6 completely recapitulated the escapers phenotype.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5: The SPAZ promoter. (A) Schematic representation of the SPO13 promoter with 
URS1 sequence (purple box), the SPAL5 promoter with 5 GAL4 binding sites (turquoise 
boxes) and the SPAZ promoter with the 6 repeats of the Z4 binding site (orange boxes). (B) 
The SPAZ promoter used to drive our 3 top safeguard genes: FAS2, RPB11 and SEC4. Serial 
dilutions of all strains compared to their shuffle strains containing the ZEV expressing 
plasmid were plated on YPD media with or without 1 µM estradiol. (C) Growth of all three 
SPAZ safeguard strains was measured compared to BY4741 wild type strain in YPD medium 
containing 30 nM estradiol. (D) Metabolomics analysis presented as a heat-map of the fold 
change from each metabolite analyzed. Safeguard strains used were NAy484 (FAS2), NAy486 
(RPB11) and NAy488 (SEC4), control – NAy497.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Engineering the TET promoter (A) Schematic representation of the TET, SPET 
and 3xSPET with ADH1 transcription terminator sequence (purple box), the tetO repeats 
(blue triangles) and CYC1 TATA region (green arrow), arrow heads indicate TATA box 
location and SspI restriction site. For the SPET promoter a single URS1 sequence was cloned 
into the SspI site. for 3xSPET three repeats of the URS1 sequence (with linkers) were cloned 
to the SspI site. (B) The TET (2 isolates), SPET (2 isolates) and 3xSPET (4 isolates) 
promoters used to drive the SEC4 gene. Serial dilutions of all strains compared to the shuffle 
strain were plated on YPD medium with or without 10g/ml Doxycycline.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Decoy molecules - effect on transcription. Graphical representation of the 
number of transcripts/genes changed in response to each specific candidate decoy 
compound and concentration. BY4741 WT cells were grown in liquid culture in the 
presence of each candidate decoy molecule (_1 and _100 represent 1 and 100 µM 
respectively) and subjected to transcriptome analysis. Compounds/concentrations useful in 
“decoy mode” are indicated in red. 
 
 
 
 
 
 
 
 
 
 
